Miami、FLにおける大うつ病性障害の臨床試験
Miamiとその周辺地域（約30マイル以内）の拠点で、大うつ病性障害に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
被験者募集中第3相
- Miami Jewish health, Miami
- Quantix Research - Miami - Southwest 72nd Street, Miami
- Diverse Clinical Research, Miami
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
被験者募集中第3相
- Pharmax Research Clinic Inc, Miami
- Nuovida Research Center, Miami
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
被験者募集中第3相
- Pharmax Research Clinic Inc, Miami
- Miami Dade Medical Research Institute, Miami
- Nuovida Research Center, Miami
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
被験者募集中第2相
- Central Miami Medical Institute Llc., Miami
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
被験者募集中第3相
- Premier Clinical Research Institute, Miami
- Miami Jewish Health System, Miami
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
被験者募集中第3相
- Vanda Investigational Site, Miami
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
被験者募集中第4相
- Neurocrine Clinical Site, Miami
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
被験者募集中第2相
- Draig Clinical Site, Miami
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
被験者募集中第3相
- Neurocrine Clinical Site, Miami
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
被験者募集中第3相
- PharmaSouth Research, Miami
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
被験者募集中第2相
- Premier Clinical Research Institute, Inc., Miami
- Miami Dade Medical Research Institute, Miami
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
被験者募集中第2相
- Premier Clinical Research Institute Inc, Miami
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
被験者募集中第3相
- Neurocrine Clinical Site, Miami
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
被験者募集中第3相
- Clinical Research Site, Miami
- Clinical Research Site, Miami
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
被験者募集中第2相
- GMI Florida - Central Miami Medical Institute /ID# 278218, Miami
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
被験者募集中第2相
- Bioresearch Partner, Miami
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
被験者募集中第2相
- Autobahn Site #111, Miami
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
被験者募集中第4相
- Clinical Research Site, Miami
他の都市における大うつ病性障害の試験
- New York City, NY37件の研究
- Boston, MA31件の研究
- Atlanta, GA25件の研究
- Philadelphia, PA23件の研究
- Orlando, FL19件の研究
- Tampa, FL17件の研究
- Chicago, IL17件の研究
- Houston, TX16件の研究
- San Diego, CA16件の研究
- Little Rock, AR14件の研究
- Orange, CA13件の研究
- Austin, TX13件の研究
Miamiにおける他の研究
- 乳がん42件の研究
- がん（全種類）36件の研究
- 非小細胞肺癌31件の研究
- 前立腺がん27件の研究
- 肥満症27件の研究
- 急性骨髄性白血病24件の研究
- 転移性癌24件の研究
- 卵巣がん23件の研究
- 過体重23件の研究
- 多発性骨髄腫21件の研究
- 潰瘍性大腸炎21件の研究
- アルツハイマー病20件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。